CAMBRIDGE – Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced mRNA-1345, an investigational mRNA vaccine candidate for respiratory syncytial virus (RSV), has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) in adults aged 60 years or older. The designation was …
Louisiana – Emergency physician and a clinical scientist from Louisiana, Joseph Fraiman, says the messenger RNA Covid-19 vaccine, Pfizer & Moderna, can have adverse affect people including cardiac arrest. He said: “We found the vaccine increases serious adverse events at a rate of one in 800. At the time of the publication, my co-authors and I did not believe our …
CAMBRIDGE – Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, participation in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference on Dec 1, live webcast. Presentation is available under “Events and Presentations” in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna’s website …
New York – After vaccinations, some people were found unconscious and were diagnosed with myocarditis, an inflammation of the heart muscle, and pericarditis, an inflammation of the outer lining of the heart. Moderna has already launched two trials, the recent one in September; Pfizer also at least one. The FDA wants drugmakers to conduct several studies assessing the potential long-term …
Quebec – Amid global economic uncertainty, the Government of Canada will continue to be there for people – just like we were throughout the pandemic. By continuing to attract investment in research and development and manufacturing, we will continue to create good, middle class jobs and build an economy that works for all Canadians. Prime Minister Justin Trudeau, took part …
Primary series CDC does not recommend mixing products for your primary series doses. If you received Pfizer-BioNTech or Moderna COVID-19 for the first dose of your primary series, you should get the same product for all following primary series doses. Boosters People ages 18 years and older may get a different product for a booster than they got for their …
CAMBRIDGE – Moderna, Inc, (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending a variation to the conditional marketing authorization (CMA) to include a booster dose of Spikevax, the Company’s COVID-19 vaccine, at the 50 µg …
New York – Omicron sub-variants evades antibody responses from Covid vaccines but a new lab study suggests that the current booster doses can be effective. University of Washington researchers saw the functional impact of mutations in Omicron sub-variants. They used Moderna, Pfizer, Novavax, Janssen, AstraZeneca, Sinopharm, and Sputnik V vaccines. All two-dose vaccines, except for Janssen’s single dose vaccine were …
CAMBRIDGE – Moderna, Inc. has announced new clinical data on its bivalent (Omicron) COVID booster candidate, mRNA-1273.214. One month after administration in previously vaccinated and boosted participants, a 50 µg booster dose of mRNA-1273.214 elicited potent neutralizing antibody responses against the Omicron subvariants BA.4 and BA.5 in all participants regardless of prior infection. Based on this and prior data, the …
New Delhi – The Covid-19 vaccinations did some harm along with some good to people, especially women as they complained of irregular periods. The paper – “Understanding the trauma of menstrual irregularity after Covid vaccination: a bird’s-eye view of female immunology” – has compiled data from the reports of three countries showing significant figures on this subject. A US cohort …
